In Vivo Photopolymerization: Achieving Detailed Conducting Patterns for BioelectronicsShow others and affiliations
2024 (English)In: Advanced Science, E-ISSN 2198-3844, Vol. 11, no 48, article id e2408628Article in journal (Refereed) Published
Abstract [en]
Bioelectronics holds great potential as therapeutics, but introducing conductive structures within the body poses great challenges. While implanted rigid and substrate-bound electrodes often result in inflammation and scarring in vivo, they outperform the in situ-formed, more biocompatible electrodes by providing superior control over electrode geometry. For example, one of the most researched methodologies, the formation of conductive polymers through enzymatic catalysis in vivo, is governed by diffusion control due to the slow kinetics, with curing times that span several hours to days. Herein, the discovery of the formation of biocompatible conductive structures through photopolymerization in vivo, enabling spatial control of electrode patterns is reported. The process involves photopolymerizing novel photoactive monomers, 3Es (EDOT-trimers) alone and in a mixture to cure the poly(3, 4-ethylenedioxythiophene)butoxy-1-sulfonate (PEDOT-S) derivative A5, resulting in conductive structures defined by photolithography masks. These reactions are adapted to in vivo conditions using green and red lights, with short curing times of 5-30 min. In contrast to the basic electrode structures formed through other in situ methods, the formation of specific and layered patterns is shown. This opens up the creation of more complex 3D layers-on-layer circuits in vivo.
Place, publisher, year, edition, pages
WILEY , 2024. Vol. 11, no 48, article id e2408628
Keywords [en]
biocompatibility, bioelectronics; in vivo; photolithography; photopolymerization
National Category
Other Chemical Engineering
Identifiers
URN: urn:nbn:se:liu:diva-210170DOI: 10.1002/advs.202408628ISI: 001357568400001PubMedID: 39509564Scopus ID: 2-s2.0-85208231089OAI: oai:DiVA.org:liu-210170DiVA, id: diva2:1917653
Note
Funding Agencies|European Research Council; Lund University Strategic Research Areas MultiPark; NanoLund; Lund University Bioimaging Centre; Swedish Research Council; Swedish Foundation for Strategic Research [RMX18-0083]; Trygger Foundation; Crafoord Foundation; Novo Nordisk Foundation Distinguished Innovator Grant [0087092]; [AdG 2018]; [834677]
2024-12-032024-12-032025-02-26